2018
DOI: 10.1016/j.parint.2017.11.004
|View full text |Cite
|
Sign up to set email alerts
|

Bovine babesiosis: Cattle protected in the field with a frozen vaccine containing Babesia bovis and Babesia bigemina cultured in vitro with a serum-free medium

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
19
0
4

Year Published

2020
2020
2022
2022

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 25 publications
(24 citation statements)
references
References 30 publications
1
19
0
4
Order By: Relevance
“…Once established in in vitro cultivation it was continuously cultivated for almost five consecutive years in the laboratory with passes every 72 or 96 hrs (at least 500 sub-cultures in cultivation). Thereafter, the in vitro culture of the B. bigemina was carried out discontinuously and with an indefinite number of passes in cultivation; it was grown for short periods of time (one or two months), just until enough material was obtained for experiments that were conducted during the development of the attenuated live vaccine (periods 1991-1998 and 2001-2006) and immediately frozen down in liquid nitrogen until other experiments were conducted in the period 2011-2017 in which it was cultivated for the latest experiments (tick transmissibility) and immunogenicity validation [17,18,23,24,26] until now when sequencing was carried out. More importantly to note is that the attenuated biological material has not been passed through a bovine host since its original isolation unlike the virulent isolate (from which the attenuate strain was selected) and that is replicated in animals whenever required.…”
Section: Parasitesmentioning
confidence: 99%
See 1 more Smart Citation
“…Once established in in vitro cultivation it was continuously cultivated for almost five consecutive years in the laboratory with passes every 72 or 96 hrs (at least 500 sub-cultures in cultivation). Thereafter, the in vitro culture of the B. bigemina was carried out discontinuously and with an indefinite number of passes in cultivation; it was grown for short periods of time (one or two months), just until enough material was obtained for experiments that were conducted during the development of the attenuated live vaccine (periods 1991-1998 and 2001-2006) and immediately frozen down in liquid nitrogen until other experiments were conducted in the period 2011-2017 in which it was cultivated for the latest experiments (tick transmissibility) and immunogenicity validation [17,18,23,24,26] until now when sequencing was carried out. More importantly to note is that the attenuated biological material has not been passed through a bovine host since its original isolation unlike the virulent isolate (from which the attenuate strain was selected) and that is replicated in animals whenever required.…”
Section: Parasitesmentioning
confidence: 99%
“…This ability has been demonstrated after one passage in susceptible cattle [16,[19][20][21]. Furthermore, this type of live attenuated vaccine has the great advantage conferred by its in vitro production: a low risk of contamination with other infectious agents [22][23][24], a highly parasitized suspension of red blood cells and the possibility of relatively large scale vaccine production [25]. Importantly, it was shown that the attenuated Babesia bigemina S strain was not transmitted by ticks after several passages in susceptible cattle [26].…”
Section: Introductionmentioning
confidence: 99%
“…More recently, a live vaccine containing B. bovis and B. bigemina -infected erythrocytes cultured in vitro with a serum-free medium was assessed for protection conferred to naïve cattle, under natural tick-challenge in a high endemicity zone for Babesia spp. Vaccinated animals with Babesia-infected erythrocytes derived from both the serum-free culture system or the traditional bovine serum-containing culture system showed an excellent protection level, whereas the control unvaccinated animals were not protected and showed severe clinical signs, closely related to bovine babesiosis ( 113 ).…”
Section: Experience On Live Attenuated Vaccines From In Vitmentioning
confidence: 99%
“…Studies on the improvement of the in vitro culture system of B. bovis and B. bigemina have demonstrated that it is possible to expand from a flask of 72 cm 2 containing a PPE of 4% to a perfusion bioreactor, steadily increasing the maximal PPE up to 30% while harvesting material every 24 h. This has been achieved for both B. bovis and B. bigemina culture systems which implies obtaining a larger number of vaccine doses in a shorter period ( 92 , 113 ).…”
Section: Experience On Live Attenuated Vaccines From In Vitmentioning
confidence: 99%
“…Additionally, both species differ morphologically at different developmental stages and cannot always be distinguished through microscopic techniques. Consequently, a number of efforts have been directed towards developing molecular as well as serological tests to detect infection with B. bovis and/or B. bigemina , since co-infection with both pathogens has also been documented [ 42 , 43 , 44 , 45 ]. Thus, immunofluorescence antibody assays (IFA) have been developed to detect animals exposed to the different bovine Babesia spp.…”
Section: Epidemiology and Diagnostic Tools For The Detection And Cmentioning
confidence: 99%